Page last updated: 2024-09-05

3,3',5-triiodothyronamine and Cardiomyopathy, Congestive

3,3',5-triiodothyronamine has been researched along with Cardiomyopathy, Congestive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agacdiken, A; Kahraman, G; Komsuoglu, B; Kozdag, G; Sahin, T; Ural, D; Ural, E; Vural, A1

Other Studies

1 other study(ies) available for 3,3',5-triiodothyronamine and Cardiomyopathy, Congestive

ArticleYear
Relation between free triiodothyronine/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy.
    European journal of heart failure, 2005, Volume: 7, Issue:1

    Topics: Adult; Aged; Cardiomyopathy, Dilated; Case-Control Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Severity of Illness Index; Stroke Volume; Survival Rate; Thyroxine; Triiodothyronine; Ultrasonography

2005